Latest Survival news
Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma
posted February 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Second Annual National Cancer Database Report Presented for 2022
posted February 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Addition of Palbociclib Improves PFS in HR-Positive, HER2-Positive Metastatic Breast Cancer
posted February 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Barriers to, Facilitators of Survivorship Care Identified for Childhood Cancer Survivors
posted January 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum Related Articles
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
KRAS ctDNA Linked to Worse Overall Survival in Localized Pancreatic Cancer 
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Hematologic Cancer Survivors Face Higher Risk of Developing Cardiovascular Disease Monthly Specialist Briefings
Stay Connected
